A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation
Clinical trial NCT02906020 · TERMINATED
Trial details
- NCT number
- NCT02906020
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-15
- Primary completion
- 2020-12-18
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.